✦ LIBER ✦

Doxorubicin and paclitaxel in advanced breast carcinoma : Importance of prior adjuvant anthracycline therapy

✍ Scribed by Ana Lluch; Belén Ojeda; Ramon Colomer; Agustí Barnadas; Bartomeu Massuti; Antonio Casado; Cristina Angeles; Pablo Maroto

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 88 KB
Volume: 89
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20001201)89:11<2169::aid-cncr4>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of radiation therapy in the man

The role of radiation therapy in the management of locally advanced carcinoma of the breast

✍ Jay R. Harris; Samuel Hellman 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB 👁 2 views

A phase II trial of neoadjuvant methotre

A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma

✍ Louise E. Morrell; Young J. Lee; Judith Hurley; Mayda Arias; Carolyn Mies; Steph 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: Traditionally, primary surgical therapy is considered unsuitable for the treatment of patients with locally advanced breast carcinoma (labc). multiple reports have documented the efficacy of primary chemotherapy in this group of patients. the purpose of this study was to investigate

Effect of adjuvant chemotherapy on outco

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy

✍ Jean-Yves Pierga; Bernard Asselain; Michel Jouve; Véronique Diéras; Mathieu Cart 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## BACKGROUND. The objective of the current study was to analyze the impact of adjuvant chemotherapy in comparison with other prognostic parameters on the outcome of a series of patients with breast carcinoma at time of metastatic recurrence. ## METHODS. Data from 1430 patients accrued in 8 pro

A prospective, randomized phase III tria

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

✍ Cesar Blajman; L. Balbiani; J. Block; F. Coppola; R. Chacon; L. Fein; S. Bonicat 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Background: A prospective, multicenter, randomized, phase iii trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (fac) with a combination of vinorelbine and doxorubicin (na) in the treatment of patients with advanced breast carcinoma w

Chemotherapy with an every-2-week regime

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy

✍ Cora N. Sternberg; Fabio Calabrò; Giorgio Pizzocaro; Luca Marini; Sylvia Schnetz 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 1 views

High response rate with a lower dose of

High response rate with a lower dose of paclitaxel in combination with cisplatin in heavily pretreated patients with advanced breast carcinoma

✍ Abdel G. Maiche; Antti P. Jekunen; Jaana Kaleva-Kerola; Guillermo Blanco Sequeir 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

## BACKGROUND. Paclitaxel has been found to be efficacious in the treatment of breast carcinoma either when administered alone or in combination with other anticancer agents. Synergistic interaction between paclitaxel and cisplatin has been demonstrated in vitro. ## METHODS. Thirty-two patients w